Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

Sebela Pharmaceuticals, a pharma company that focuses on GI health, has entered an exclusive partnership to license GI medication tegoprazan in the U.S. and Canada. The medication works as an acid ...

A rise in popularity in glucagon-like peptide 1 receptor agonists such as Ozempic and Wegovy is causing concern in the medical community over potential side effects for various physician specialties, ...

Identify and compare mechanisms of action, safety, tolerability, and efficacy profiles of emerging therapies for common gastrointestinal (GI) disorders Recognize the roles of emerging therapies for ...

Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...

The designation is supported by data from the 12-week, randomized, double-blind phase 2 FILLMORE trial. The Food and Drug Administration (FDA) has granted Orphan Drug designation to AMT-101 for the ...

What Is a GI Cocktail? A gastrointestinal (GI) cocktail is a mixture of medications used to treat indigestion (dyspepsia), as well as symptoms of gastrointestinal problems such as chest and belly pain ...

Discover a groundbreaking treatment for gastrointestinal wounds with a new acid-resistant hydrogel developed by PolyU ...

Capecitabine is an oral chemotherapy used to treat many gastrointestinal cancers. Its complex dosing and narrow therapeutic index make medication adherence and toxicity management crucial for quality ...

Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital An institutional review board–approved study was ...